Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Clin Cancer Res. 2020 Sep 17;26(22):5860–5868. doi: 10.1158/1078-0432.CCR-20-2276

Table 2:

Toxicity Evaluation

Side Effects (N = 19 Patients)
G1 No (%) G2 No (%) G3 No (%)

Rash (skin) 16 (84) 1 (5) 1 (5)
Pruritus/Dry skin 13 (68) 1 (5) 0
Fatigue 10 (53) 1 (5) 0
Diarrhea 10 (53) 1 (5) 0
Hair thinning 4 (21) 0 0
Anxiety/sleep disorder 3 (16) 0 0
Tongue pain 3 (16) 0 0
Indigestion 3 (16) 0 0
Nausea 4 (21) 0 0
Epistaxis 1 (5) 1 (5) 0
Anemia 3 (16) 0 0
Thrombocytopenia 1 (5) 0 0
SGOT/SGPT elevation 8 (42) 0 0
Hypertension 2 (11) 1 (5) 2 (11)
Hyperglycemia 5 (26) 0 0
Hypokalemia 2 (11) 0 0

G1 - Grade 1, G2 - Grade 2, G3 - Grade 3.